Skip to main content
You have permission to edit this article.
Theravance Bio: 4Q Earnings Snapshot

Theravance Bio: 4Q Earnings Snapshot

  • Updated
  • 0

GEORGE TOWN, Cayman Islands (AP) — Theravance Biopharma Inc. (TBPH) on Tuesday reported a loss of $58.4 million in its fourth quarter.

On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of 92 cents.

The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.03 per share.

The biopharmaceutical company posted revenue of $18.7 million in the period, missing Street forecasts. Five analysts surveyed by Zacks expected $18.9 million.

For the year, the company reported that its loss widened to $278 million, or $4.46 per share. Revenue was reported as $71.9 million.

Theravance Bio shares have decreased roughly 1% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $17.65, a drop of 25% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on TBPH at

Copyright by Automated Insights, Inc. All rights reserved.

The business news you need

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Related to this story

Most Popular

LAMAR – Stepping through the front door of Lamar’s newest restaurant on Main Street, guests will experience “A Lil’ Tast’a Cajun” from the Louisiana swamp scene painted on the walls to the smell of Cajun food wafting from the kitchen to the dining room where Cajun-style music plays.

  • Updated

DALLAS (AP) — MoneyGram International Inc. (MGI) on Monday reported fourth-quarter net income of $7.3 million, after reporting a loss in the same period a year earlier.

Get up-to-the-minute news sent straight to your device.


Breaking News

News Alert